17 May 2023
RNZ's Kathryn Ryan talks to our Clinical Director Dr Rob Weinkove about our CAR T-cell clinical trial, what a recent commercial deal with global pharmaceutical Dr. Reddy's means and his ambition to see this become a mainstream treatment.
Related articles
Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy
23 July 2024
Read more
RNZ Our Changing World: Targeting bacteria, and health inequities
4 July 2024
Read more
New clinical research aims to reduce stomach cancer rates and disparities in New Zealand
28 May 2024
Read more
A revolution in cancer care is near; here’s what’s needed to make it happen
9 May 2024
Read more
Significant milestone reached in first NZ CAR T-cell trial as preparations made for larger phase 2 registration trial
25 March 2024
Read more
RNZ: Engineering immune cells to kill cancer
5 November 2023
Read more